Kōmmour Prenatal for Prenatal Health Disparities among Marshallese Pregnant Women
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on improving the health of Marshallese Pacific Islander pregnant women and their babies. It tests a program called Kōmmour Prenatal, which provides group prenatal care tailored to the cultural needs of the Marshallese community. The goal is to determine if this program can reduce health disparities and improve outcomes for mothers and infants. Women who identify as Marshallese, are between 8 to 20 weeks pregnant, and are interested in culturally specific prenatal care may be suitable for this trial. As an unphased trial, this study offers a unique opportunity to contribute to culturally tailored healthcare solutions.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Kōmmour Prenatal program is safe for Marshallese pregnant women?
Research has shown that the Kōmmour Prenatal program is being studied to improve the health of Marshallese pregnant women. Although specific studies on its safety are lacking, this program employs a group prenatal care approach. It provides support and information in a group setting, rather than introducing a new drug or medical device.
Programs like this generally aim to enhance health through education and support, which are typically safe. The study focuses on evaluating the program's effectiveness, suggesting it is expected to be well-received. No reports of negative effects linked to the Kōmmour Prenatal program appear in the sources provided, indicating that the program is considered safe for participants.12345Why are researchers excited about this trial?
Kōmmour Prenatal is unique because it specifically targets prenatal health disparities among Marshallese pregnant women, a group often underserved by typical prenatal care options like standard prenatal vitamins and routine check-ups. Researchers are excited about Kōmmour Prenatal because it is designed to address cultural and genetic factors unique to the Marshallese population, potentially leading to more effective and personalized prenatal care. Unlike conventional treatments that take a one-size-fits-all approach, Kōmmour Prenatal aims to offer a tailored solution, which could lead to better health outcomes for both mothers and their babies.
What evidence suggests that Kōmmour Prenatal is effective for reducing health disparities among Marshallese pregnant women?
Research shows that the Kōmmour Prenatal program is specially designed for Marshallese pregnant women to help reduce health disparities. Early findings suggest that over half of Marshallese women miss important prenatal check-ups, potentially leading to health problems. Kōmmour Prenatal, based on the CenteringPregnancy model, aims to improve health by offering group care that respects their culture. This method has succeeded in other communities in improving the health of mothers and babies. While specific data on its effectiveness for Marshallese women is still being collected, the program builds on proven methods used in similar group prenatal care settings.12678
Who Is on the Research Team?
Britni Ayers, PhD
Principal Investigator
University of Arkansas for Medical Sciences Northwest
Are You a Good Fit for This Trial?
This trial is for Marshallese women who are at least 18 years old and between 8-20 weeks pregnant. It aims to help reduce health issues for mothers and babies by adapting a group prenatal program specifically for their community.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in the Kōmmour Prenatal program to reduce maternal and infant health disparities
Follow-up
Participants are monitored for outcomes such as gestational weight gain, breastfeeding initiation, and birth weight of infant
What Are the Treatments Tested in This Trial?
Interventions
- Kōmmour Prenatal
Kōmmour Prenatal is already approved in United States for the following indications:
- Reducing maternal and infant health disparities among Marshallese Pacific Islander women
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arkansas
Lead Sponsor